3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
40
Lung Neoplasms
34
Leukemia, Myeloid, Acute
34
Breast Neoplasms
31
Multiple Myeloma
25
Carcinoma, Non-Small-Cell Lung
25
Colorectal Neoplasms
23
Prostatic Neoplasms
21
Pancreatic Neoplasms
20
Melanoma
17
Carcinoma, Renal Cell
17
Lymphoma
16
Urinary Bladder Neoplasms
15
Triple Negative Breast Neoplasms
15
Ovarian Neoplasms
14
Myelodysplastic Syndromes
14
Burkitt Lymphoma
12
Lymphoma, Large B-Cell, Diffuse
11
Squamous Cell Carcinoma of Head and Neck
10
Sarcoma
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Glioma
10
Fallopian Tube Neoplasms
10
Mouth Neoplasms
9
Endometrial Neoplasms
9
Carcinoma, Transitional Cell
9
Carcinoma, Hepatocellular
9
Carcinoma
9
Oropharyngeal Neoplasms
8
Laryngeal Neoplasms
8
Interventions
Cyclophosphamide
8
asciminib
7
fludarabine phosphate
6
fludarabine
5
Mycophenolic Acid
5
nilotinib
3
Whole-Body Irradiation
3
Thiotepa
3
Tacrolimus
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporine
3
venetoclax
2
Sirolimus
2
Melphalan
2
Filgrastim
2
Dasatinib
2
Cyclosporins
2
treosulfan
1
thymoglobulin
1
selinexor
1
ruxolitinib
1
ponatinib
1
plerixafor
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Specimen Handling
×
30 days
×
Clear all
No trials found.